Advertisement

Topics

Aprogen/Nichi-Iko's Remicade Biosimilar Clears Japan’s Approval Review

09:38 EDT 9 Aug 2017 | SCRIP

South Korea's Aprogen, which has teamed up with Japan's Nichi-Iko, is set to receive an official regulatory approval for its...

      

Related Stories

 

Original Article: Aprogen/Nichi-Iko's Remicade Biosimilar Clears Japan’s Approval Review

NEXT ARTICLE

More From BioPortfolio on "Aprogen/Nichi-Iko's Remicade Biosimilar Clears Japan’s Approval Review"

Quick Search
Advertisement